Ritholtz Wealth Management Abbott Laboratories Transaction History

Ritholtz Wealth Management

$2.87 Billion
Q1 2024

A detailed history of Ritholtz Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Ritholtz Wealth Management holds 40,897 shares of ABT stock, worth $4.18 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

40,897

Previous 37,046 10.4%

Holding current value

$4.18 Million

Previous $4.08 Million 14.01%

% of portfolio

0.16%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $421,761 - $465,816	3,851 Added 10.4%	40,897 $4.65 Million
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $76,481 - $93,619	848 Added 2.34%	37,046 $4.08 Million
Q3 2023 Oct 13, 2023	BUY	$95.53 - $114.62 $336,743 - $404,035	3,525 Added 10.79%	36,198 $3.51 Million
Q2 2023 Jul 14, 2023	BUY	$100.78 - $112.29 $560,739 - $624,781	5,564 Added 20.52%	32,673 $3.56 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $2.97 Million - $3.49 Million	-30,634 Reduced 53.05%	27,109 $2.75 Million

Q4 2022 Jan 18, 2023	BUY	$95.06 - $111.52 $2.49 Million - $2.93 Million	26,246 Added 83.33%	57,743 $0
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $306,729 - $355,135	3,170 Added 11.19%	31,497 $3.05 Million
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $1.28 Million - $1.55 Million	-12,577 Reduced 30.75%	28,327 $3.08 Million
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $3.58 Million - $4.37 Million	31,394 Added 330.12%	40,904 $4.84 Million
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $213,846 - $261,842	1,851 Added 24.17%	9,510 $1.34 Million
Q3 2021 Oct 14, 2021	BUY	$116.66 - $129.06 $238,103 - $263,411	2,041 Added 36.33%	7,659 $905,000
Q2 2021 Jul 20, 2021	SELL	$105.79 - $124.53 $100,394 - $118,178	-949 Reduced 14.45%	5,618 $651,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $204,292 - $240,687	1,877 Added 40.02%	6,567 $787,000
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $82,215 - $89,590	783 Added 20.04%	4,690 $514,000
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $63,598 - $77,235	694 Added 21.6%	3,907 $425,000
Q2 2020 Jul 15, 2020	BUY	$76.57 - $98.0 $246,019 - $314,874	3,213 New	3,213 $294,000
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $316,110 - $462,239	-5,032 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $1,413 - $1,573	-18 Reduced 0.36%	5,032 $437,000
Q3 2019 Oct 17, 2019	BUY	$81.84 - $88.74 $29,380 - $31,857	359 Added 7.65%	5,050 $423,000
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 2.09%	4,691 $375,000
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $6,556 - $7,427	-100 Reduced 2.04%	4,791 $347,000
Q3 2018 Oct 12, 2018	SELL	$60.81 - $73.36 $7,722 - $9,316	-127 Reduced 2.53%	4,891 $359,000
Q2 2018 Jul 12, 2018	BUY	$57.57 - $63.54 $5,929 - $6,544	103 Added 2.1%	5,018 $306,000
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $1,350 - $1,526	24 Added 0.49%	4,915 $295,000
Q4 2017 Jan 23, 2018	BUY	$53.68 - $57.47 $262,548 - $281,085	4,891	4,891 $279,000

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Abbott Laboratories Transaction History